Sign in

CIK 0001672619

  • Non-accelerated filer

Enliven Therapeutics, Inc.

Sign in to watch
Ticker
ELVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
811523849
Phone
+1 650-547-5814
Business address
205 PARK ROAD, BURLINGAME, CA, 94010
Former names
IMARA Inc.
  1. 4 Planned sale CHIEF MEDICAL OFFICER sold 5,000 shares at an average $39.79 ($198,971)
  2. 4 Planned sale CHIEF MEDICAL OFFICER sold 5,000 shares at an average $47.67 ($238,352)
  3. 4 Planned sale CHIEF MEDICAL OFFICER sold 40,000 shares at $35.10 ($1,404,024)
  4. 4 Planned sale CHIEF MEDICAL OFFICER sold 5,000 shares at $27.76 ($138,800)
  5. 4 Planned sale CHIEF MEDICAL OFFICER sold 40,000 shares at an average $30.07 ($1,202,638)
  6. 4 Open-market sale CHIEF FINANCIAL OFFICER sold 10,000 shares at $29.58 ($295,839)
  7. 4 Planned sale Director sold 1,230 shares at $26.18 ($32,196)
  8. 4 Planned sale CHIEF MEDICAL OFFICER sold 45,000 shares at $26.17 ($1,177,862)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Grant or award CHIEF OPERATING OFFICER acquired 20,000 shares (grant or award)
  17. 4 Grant or award CHIEF SCIENTIFIC OFFICER acquired 18,750 shares (grant or award)
  18. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 25,000 shares (grant or award)
  19. 4 Grant or award CHIEF MEDICAL OFFICER acquired 25,000 shares (grant or award)
  20. 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 5,000 shares at $29.04 ($145,219)

Page 2 of 20 · 383 filings